90
Participants
Start Date
April 30, 2016
Primary Completion Date
November 22, 2019
Study Completion Date
October 30, 2020
Myrcludex B
Lyophilised powder for solution for subcutaneous injection
PEG IFN alfa-2a
solution for subcutaneous injection, once per week
Tenofovir
Film-coated tablets, 300 mg, per os, once daily
Moscow Regional Research and Clinical Institute, Moscow
"State Budgetary educational institution of higher professional education South Ural State Medical University Ministry of healthcare", Chelyabinsk
"State Budgetary Institution of healthcare Specialized Clinical Infectious Diseases Hospital Ministry of Health", Krasnodar
"Federal Budget Institution of Science Central Research Institute of Epidemiology of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance", Moscow
"LLC Clinic of Modern Medicine", Moscow
"Medical Company Gepatolog LLC", Samara
State Budgetary Institution of healthcare 'Stavropol regional clinical hospital', Stavropol
Lead Sponsor
Hepatera Ltd.
INDUSTRY